American Society of Clinical Oncology

SHERPA: White

People

  1. Pfister
    Pfister
  2. Haque
    Haque
  3. Sherman
    Sherman
  4. Ho
    Ho
  5. Young
    Young
  6. Dunn
    Dunn
  7. Lee
    Lee
  8. Baxi
    Baxi
  9. De Angelis
    De Angelis
  10. Karimi
    Karimi

Groups

  1. Neuroradiology Service (79)
  2. Radiology, Department of (79)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (56)
  5. Head and Neck Service (37)
  6. Biostatistics Service (33)
  7. Epidemiology and Biostatistics (33)
  8. GSK Faculty (31)
  9. Survivorship Research (25)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
Search Within
  1. "Neuroradiology Service"
Formats
  1. Meeting Abstract (59)
  2. Journal Article (19)
  3. Guidelines (1)
Groups
  1. Neuroradiology Service (79)
  2. Radiology, Department of (79)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (56)
  5. Head and Neck Service (37)
  6. Biostatistics Service (33)

More Groups

People
  1. David Pfister (37)
  2. Sofia Haque (33)
  3. Eric Sherman (32)
  4. Alan Ho (25)
  5. Robert Young (19)
  6. Matthew Fury (17)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (6)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. JCO Precision Oncology (6)

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II window of irinotecan plus carboplatin in newly diagnosed patients with rhandomyosarcoma: Results of Memorial Sloan-Kettering Cancer Center (MSKCC) Protocol IRB 03-099
    Meeting Abstract

    Wexler, L. H.; Wolden, S. L.; Abramson, S. J.; Price, A.; Karimi, S.; La Quaglia, M. P.; Chou, A. J.; Merola, P. R.; Meyers, P. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Pfister, D. G.; Haque, S.; Stambuk, H.; Lisa, D. M.; Shen, R.; Carlson, D.; Fury, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Wu, N.; Haque, S.; Lisa, D. M.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of depsipeptide (DEP) in radioiodine (RAI)-refractory metastatic nonmedullary thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Fury, M. G.; Tuttle, R. M.; Ghossein, R.; Stambuk, H.; Baum, M.; Lisa, D.; Su, Y. B.; Shaha, A.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Meeting Abstract

    Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases
    Meeting Abstract

    Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results
    Meeting Abstract

    Fury, M. G.; Sherman, E.; Stambuk, H.; Haque, S.; Lisa, D.; Shen, R.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save